Adult Cardiac Surgery Department, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
Cardiac Surgery Department, King Fahd Medical City, Riyadh, Saudi Arabia.
Asian Cardiovasc Thorac Ann. 2023 Jun;31(5):413-420. doi: 10.1177/02184923231176508. Epub 2023 May 16.
Tricuspid valve repair (TVr) is the recommended approach for managing tricuspid regurgitation; however, there is a concern about the long-term durability of the repair. Therefore, this study aimed to compare the long-term outcomes of TVr versus tricuspid valve replacement (TVR) in a matched cohort of patients.
This study included 1161 patients who underwent tricuspid valve (TV) surgery from 2009 to 2020. Patients were grouped according to the procedure into two groups: patients who underwent TVr ( = 1020) and patients who underwent TVR (n = 159). The propensity score identified 135 matched pairs.
Renal replacement therapy and bleeding were significantly higher in the TVR group compared to the TVr group both before and after matching. Thirty-day mortality occurred in 38 (3.79%) patients in TVr group versus 3 (1.89%) in the TVR group ( ≤ 0.001) but was not significant after matching. After matching, TV reintervention (hazard ratio (HR): 21.44 (95% CI: 2.17-211.95); = 0.009) and heart failure rehospitalization (HR: 1.89 (95% CI: 1.13-3.16); = 0.015) were significantly higher in the TVR group. There was no difference in mortality in the matched cohort (HR: 1.63 (95% CI: 0.72-3.70); = 0.25).
TVr was associated with lower renal impairment, reintervention, and heart failure rehospitalization than replacement. TVr remains the preferred approach whenever feasible.
三尖瓣修复(TVr)是治疗三尖瓣反流的推荐方法;然而,人们对修复的长期耐久性存在担忧。因此,本研究旨在比较 TVr 与三尖瓣置换(TVR)在匹配患者队列中的长期结果。
本研究纳入了 2009 年至 2020 年期间接受三尖瓣(TV)手术的 1161 名患者。根据手术方式将患者分为两组:TVr 组(n=1020)和 TVR 组(n=159)。倾向评分确定了 135 对匹配。
在匹配前后,TVR 组的肾脏替代治疗和出血明显高于 TVr 组。TVr 组有 38 例(3.79%)患者在 30 天内死亡,而 TVR 组有 3 例(1.89%)死亡(≤0.001),但匹配后无统计学意义。匹配后,TV 再次干预(风险比(HR):21.44(95%CI:2.17-211.95);P=0.009)和心力衰竭再入院(HR:1.89(95%CI:1.13-3.16);P=0.015)在 TVR 组中明显更高。在匹配队列中,死亡率无差异(HR:1.63(95%CI:0.72-3.70);P=0.25)。
与置换相比,TVr 与较低的肾功能损害、再次干预和心力衰竭再入院相关。只要可行,TVr 仍然是首选方法。